155 related articles for article (PubMed ID: 34251324)
1. Untargeted lipidomics reveals specific lipid abnormalities in systemic lupus erythematosus.
Wang Y; Guo F; Guo Y; Lu Y; Ji W; Lin L; Chen W; Xu T; Kong D; Shen Q; Zhu Y; Liu P; Su J; Wang L; Li Y; Gao P; Shan J; Liu S
Clin Exp Rheumatol; 2022 May; 40(5):1011-1018. PubMed ID: 34251324
[TBL] [Abstract][Full Text] [Related]
2. Shotgun Lipidomics Revealed Altered Profiles of Serum Lipids in Systemic Lupus Erythematosus Closely Associated with Disease Activity.
Lu L; Hu C; Zhao Y; He L; Zhou J; Li H; Du Y; Wang Y; Wen C; Han X; Fan Y
Biomolecules; 2018 Oct; 8(4):. PubMed ID: 30282943
[TBL] [Abstract][Full Text] [Related]
3. Integration of metabolomics and lipidomics reveals serum biomarkers for systemic lupus erythematosus with different organs involvement.
Zhang W; Zhao H; Du P; Cui H; Lu S; Xiang Z; Lu Q; Jia S; Zhao M
Clin Immunol; 2022 Aug; 241():109057. PubMed ID: 35667550
[TBL] [Abstract][Full Text] [Related]
4. Untargeted lipidomics reveals specific lipid abnormalities in Sjögren's syndrome.
Lu J; Guo Y; Lu Y; Ji W; Lin L; Qian W; Chen W; Wang J; Lv X; Ke M; Kong D; Shen Q; Zhu Y; Liu P; Su J; Wang L; Li Y; Gao P; Shan J; Liu S
Rheumatology (Oxford); 2021 Mar; 60(3):1252-1259. PubMed ID: 32911538
[TBL] [Abstract][Full Text] [Related]
5. PGLYRP2 as a novel biomarker for the activity and lipid metabolism of systemic lupus erythematosus.
Li H; Meng D; Jia J; Wei H
Lipids Health Dis; 2021 Aug; 20(1):95. PubMed ID: 34461924
[TBL] [Abstract][Full Text] [Related]
6. UPLC-MS/MS-based plasma lipidomics reveal a distinctive signature in systemic lupus erythematosus patients.
Chen J; Liu C; Ye S; Lu R; Zhu H; Xu J
MedComm (2020); 2021 Jun; 2(2):269-278. PubMed ID: 34766146
[TBL] [Abstract][Full Text] [Related]
7. Serum metabolomic profiling in patients with systemic lupus erythematosus by GC/MS.
Yan B; Huang J; Zhang C; Hu X; Gao M; Shi A; Zha W; Shi L; Huang C; Yang L
Mod Rheumatol; 2016 Nov; 26(6):914-922. PubMed ID: 26915395
[TBL] [Abstract][Full Text] [Related]
8. Metabolomic profiling reveals serum L-pyroglutamic acid as a potential diagnostic biomarker for systemic lupus erythematosus.
Zhang Q; Li X; Yin X; Wang H; Fu C; Wang H; Li K; Li Y; Zhang X; Liang H; Li K; Li H; Qiu Y
Rheumatology (Oxford); 2021 Feb; 60(2):598-606. PubMed ID: 32259244
[TBL] [Abstract][Full Text] [Related]
9. Untargeted Lipidomics Reveals Characteristic Biomarkers in Patients with Ankylosing Spondylitis Disease.
Li Z; Gu W; Wang Y; Qin B; Ji W; Wang Z; Liu S
Biomedicines; 2022 Dec; 11(1):. PubMed ID: 36672555
[No Abstract] [Full Text] [Related]
10. Lipidomic and metabolomic profiling reveals novel candidate biomarkers in active systemic lupus erythematosus.
Li Y; Liang L; Deng X; Zhong L
Int J Clin Exp Pathol; 2019; 12(3):857-866. PubMed ID: 31933894
[TBL] [Abstract][Full Text] [Related]
11. S100A8 in Serum, Urine, and Saliva as a Potential Biomarker for Systemic Lupus Erythematosus.
Kim JW; Jung JY; Lee SW; Baek WY; Kim HA; Suh CH
Front Immunol; 2022; 13():886209. PubMed ID: 35529863
[TBL] [Abstract][Full Text] [Related]
12. Lipidomics in autoimmune diseases with main focus on systemic lupus erythematosus.
Ferreira HB; Pereira AM; Melo T; Paiva A; Domingues MR
J Pharm Biomed Anal; 2019 Sep; 174():386-395. PubMed ID: 31207360
[TBL] [Abstract][Full Text] [Related]
13. RNA-seq of circular RNAs identified circPTPN22 as a potential new activity indicator in systemic lupus erythematosus.
Miao Q; Zhong Z; Jiang Z; Lin Y; Ni B; Yang W; Tang J
Lupus; 2019 Apr; 28(4):520-528. PubMed ID: 30871426
[TBL] [Abstract][Full Text] [Related]
14. Expression profile and diagnostic value of circRNAs in peripheral blood from patients with systemic lupus erythematosus.
Luo Q; Li X; Fu B; Zhang L; Fang L; Qing C; Guo Y; Huang Z; Li J
Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33169172
[TBL] [Abstract][Full Text] [Related]
15. Microarray expression profile of circular RNAs and mRNAs in children with systemic lupus erythematosus.
Li S; Zhang J; Tan X; Deng J; Li Y; Piao Y; Li C; Yang W; Mo W; Sun J; Sun F; Han T; Wang J; Kuang W; Li C
Clin Rheumatol; 2019 May; 38(5):1339-1350. PubMed ID: 30628013
[TBL] [Abstract][Full Text] [Related]
16. Whole Blood and Plasma-Based Lipid Profiling Reveals Distinctive Metabolic Changes in Systemic Lupus Erythematosus and Systemic Sclerosis.
Ferreira HB; Melo T; Guerra IMS; Moreira ASP; Laranjeira P; Paiva A; Goracci L; Bonciarelli S; Domingues P; Domingues MR
J Proteome Res; 2023 Sep; 22(9):2995-3008. PubMed ID: 37606915
[TBL] [Abstract][Full Text] [Related]
17. Fecal Metabolites Were Altered, Identified as Biomarkers and Correlated With Disease Activity in Patients With Systemic Lupus Erythematosus in a GC-MS-Based Metabolomics Study.
Yan R; Jiang H; Gu S; Feng N; Zhang N; Lv L; Liu F
Front Immunol; 2020; 11():2138. PubMed ID: 33013903
[TBL] [Abstract][Full Text] [Related]
18. Serum leucine-rich α2-glycoprotein is elevated in patients with systemic lupus erythematosus and correlates with disease activity.
Ahn SS; Park Y; Jung SM; Song JJ; Park YB; Lee SW
Clin Chim Acta; 2018 Nov; 486():253-258. PubMed ID: 30118672
[TBL] [Abstract][Full Text] [Related]
19. Serum and urine interleukin-17A levels as biomarkers of disease activity in systemic lupus erythematosus.
Nordin F; Shaharir SS; Abdul Wahab A; Mustafar R; Abdul Gafor AH; Mohamed Said MS; Rajalingham S; Shah SA
Int J Rheum Dis; 2019 Aug; 22(8):1419-1426. PubMed ID: 31179646
[TBL] [Abstract][Full Text] [Related]
20. Urine β-2-glycoprotein 1 as a biomarker for diagnosis of systemic lupus erythematosus.
Lee JS; Lee EJ; Yeom J; Oh JS; Hong S; Lee CK; Yoo B; Kim K; Kim YG
Lupus; 2021 Jul; 30(8):1306-1313. PubMed ID: 33966541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
